Skip to Content

Counterpoint Tactical Equity A CPAEX

Medalist Rating as of | See Counterpoint Funds Investment Hub
  • NAV / 1-Day Return 18.37  /  +0.05 %
  • Total Assets 102.5 Mil
  • Adj. Expense Ratio
    2.030%
  • Expense Ratio 2.030%
  • Distribution Fee Level High
  • Share Class Type Front Load
  • Category Long-Short Equity
  • Investment Style Small Blend
  • Min. Initial Investment 5,000
  • Status Open
  • TTM Yield 1.93%
  • Turnover 391%

USD | NAV as of Apr 22, 2024 | 1-Day Return as of Apr 22, 2024, 10:10 PM GMT+0

Morningstar’s Analysis CPAEX

Will CPAEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Counterpoint Tactical Equity A’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CPAEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 8.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Spdr Sp 500 Etf Long

50.15 34.4 Mil

Jpm Ind Long 2

37.03 25.4 Mil

Jpm Ind Long 1

35.63 24.4 Mil

Fidelity Inv MM Treasury I

18.10 12.4 Mil
Cash and Equivalents

United States Treasury Bills 0%

15.26 10.5 Mil
Government

Counterpoint Quantitative Equity ETF

9.98 6.8 Mil

United States Treasury Bills 0%

7.22 5.0 Mil
Government

S&P Emini 1St Wee Jan24c 1Ef4c 4570 Index

1.22 838,338

Us Dollar Future

1.06 725,799
Cash and Equivalents

RxSight Inc

0.39 269,741
Healthcare